Ziad Hijazi

Summary

Affiliation: Uppsala University Hospital
Country: Sweden

Publications

  1. doi request reprint High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin
    Ziad Hijazi
    Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden Section of Cardiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden Electronic address
    J Am Coll Cardiol 63:52-61. 2014
  2. doi request reprint Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy
    Ziad Hijazi
    Uppsala Clinical Research Center, Dag Hammarskjolds vag 14B, Uppsala, Sweden
    Circulation 125:1605-16. 2012
  3. doi request reprint Biomarkers in atrial fibrillation: a clinical review
    Ziad Hijazi
    Uppsala Clinical Research Center UCR, Uppsala University, Uppsala Science Park, Uppsala, Sweden
    Eur Heart J 34:1475-80. 2013
  4. doi request reprint N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation)
    Ziad Hijazi
    Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden
    J Am Coll Cardiol 61:2274-84. 2013
  5. doi request reprint High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
    Ziad Hijazi
    Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden Z H, A s, U A, L W Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden Z H, U A, L W Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden A S Duke University, Medical Center, Durham, NC C B G, J H A, R D L Department of Cardiology, Oslo University Hospital and Faculty of Medicine, Institute for Clinical Medicine, University of Oslo, Oslo, Norway D A Mayo Clinic College of Medicine, Rochester, MN B J G Bristol Myers Squibb, Princeton, NJ P M Division of Emergency Care, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland V P H University of Adelaide, Adelaide, Australia J H Medical Department, Hospital Unit West, Herning Holstbro, Denmark S H Boston University Medical Center, Boston, Germany
    Circulation 129:625-34. 2014
  6. ncbi request reprint Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis
    Ziad Hijazi
    From Uppsala Clinical Research Center Z H, J O, U A, A s, L W, Department of Medical Sciences, Cardiology Z H, J O, L W, and Department of Medical Sciences, Clinical Chemistry A S, Uppsala University, Sweden Department of Cardiology, J W Goethe University, Frankfurt, Germany S H H Population Health Research Institute, Hamilton, Ontario, Canada S J C, J W E, S Y Thomas Jefferson Medical College and the Heart Center, Wynnewood, PA M D E and Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT P A R
    Circulation 129:961-70. 2014
  7. ncbi request reprint Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy
    Ziad Hijazi
    Department of Cardiology, Uppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Heart 100:1193-200. 2014
  8. doi request reprint Ticagrelor versus clopidogrel in patients with acute coronary syndromes
    Lars Wallentin
    Uppsala Clinical Research Center, Uppsala, Sweden
    N Engl J Med 361:1045-57. 2009

Detail Information

Publications8

  1. doi request reprint High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin
    Ziad Hijazi
    Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden Section of Cardiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden Electronic address
    J Am Coll Cardiol 63:52-61. 2014
    ....
  2. doi request reprint Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy
    Ziad Hijazi
    Uppsala Clinical Research Center, Dag Hammarskjolds vag 14B, Uppsala, Sweden
    Circulation 125:1605-16. 2012
    ....
  3. doi request reprint Biomarkers in atrial fibrillation: a clinical review
    Ziad Hijazi
    Uppsala Clinical Research Center UCR, Uppsala University, Uppsala Science Park, Uppsala, Sweden
    Eur Heart J 34:1475-80. 2013
    ..This review will highlight novel associations of biomarkers and outcomes in AF as well as recent progress in the use of biomarkers for risk stratification...
  4. doi request reprint N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation)
    Ziad Hijazi
    Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden
    J Am Coll Cardiol 61:2274-84. 2013
    ....
  5. doi request reprint High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
    Ziad Hijazi
    Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden Z H, A s, U A, L W Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden Z H, U A, L W Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden A S Duke University, Medical Center, Durham, NC C B G, J H A, R D L Department of Cardiology, Oslo University Hospital and Faculty of Medicine, Institute for Clinical Medicine, University of Oslo, Oslo, Norway D A Mayo Clinic College of Medicine, Rochester, MN B J G Bristol Myers Squibb, Princeton, NJ P M Division of Emergency Care, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland V P H University of Adelaide, Adelaide, Australia J H Medical Department, Hospital Unit West, Herning Holstbro, Denmark S H Boston University Medical Center, Boston, Germany
    Circulation 129:625-34. 2014
    ..High-sensitivity troponin-I (hs-TnI) measurement improves risk assessment for cardiovascular events in many clinical settings, but the added value in atrial fibrillation patients has not been described...
  6. ncbi request reprint Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis
    Ziad Hijazi
    From Uppsala Clinical Research Center Z H, J O, U A, A s, L W, Department of Medical Sciences, Cardiology Z H, J O, L W, and Department of Medical Sciences, Clinical Chemistry A S, Uppsala University, Sweden Department of Cardiology, J W Goethe University, Frankfurt, Germany S H H Population Health Research Institute, Hamilton, Ontario, Canada S J C, J W E, S Y Thomas Jefferson Medical College and the Heart Center, Wynnewood, PA M D E and Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT P A R
    Circulation 129:961-70. 2014
    ..This prespecified study investigated these outcomes in relation to renal function...
  7. ncbi request reprint Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy
    Ziad Hijazi
    Department of Cardiology, Uppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Heart 100:1193-200. 2014
    ..To evaluate the prognostic importance of transient or persistent elevations of cardiac troponin-I (cTnI) and N-terminal-B-type natriuretic peptide (NT-proBNP) in atrial fibrillation (AF)...
  8. doi request reprint Ticagrelor versus clopidogrel in patients with acute coronary syndromes
    Lars Wallentin
    Uppsala Clinical Research Center, Uppsala, Sweden
    N Engl J Med 361:1045-57. 2009
    ..Ticagrelor is an oral, reversible, direct-acting inhibitor of the adenosine diphosphate receptor P2Y12 that has a more rapid onset and more pronounced platelet inhibition than clopidogrel...